(NASDAQ: DBVT) Dbv Technologies Sa's forecast annual revenue growth rate of 246.23% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 97.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.83%.
Dbv Technologies Sa's revenue in 2025 is $5,503,000.On average, 3 Wall Street analysts forecast DBVT's revenue for 2025 to be $13,118,143,426, with the lowest DBVT revenue forecast at $928,771,996, and the highest DBVT revenue forecast at $26,280,256,393. On average, 3 Wall Street analysts forecast DBVT's revenue for 2026 to be $148,087,722,750, with the lowest DBVT revenue forecast at $143,689,077,520, and the highest DBVT revenue forecast at $153,952,583,057.
In 2027, DBVT is forecast to generate $38,625,550,580 in revenue, with the lowest revenue forecast at $22,649,386,993 and the highest revenue forecast at $56,044,253,337.